Infect Chemother.  2019 Jun;51(2):98-106. 10.3947/ic.2019.51.2.98.

The National Influenza Surveillance System of Korea

• Choi WS

• KMID: 2450866
• DOI: http://doi.org/10.3947/ic.2019.51.2.98

Abstract

Influenza is a very important respiratory infectious disease that causes seasonal epidemics and pandemics. A well-organized surveillance system is necessary to monitor and respond effectively to the epidemiologic features of influenza. Korea currently operates a national influenza surveillance system based on the clinical sentinel surveillance system, laboratory sentinel surveillance system, and hospitalization and mortality surveillance system. However, there is a need for a better national surveillance system due to a demand for various pieces of information related to influenza. This article discusses the general aspects of influenza surveillance systems and the future direction of the national influenza surveillance system of Korea.

Keyword

Influenza; Human; Sentinel surveillance; Population surveillance; Korea

MeSH Terms

Communicable Diseases
Hospitalization
Humans
Influenza, Human*
Korea*
Mortality
Pandemics
Population Surveillance
Seasons
Sentinel Surveillance

Reference

1. Cassini A, Colzani E, Pini A, Mangen MJ, Plass D, McDonald SA, Maringhini G, van Lier A, Haagsma JA, Havelaar AH, Kramarz P, Kretzschmar ME. On Behalf Of The BCoDE Consortium. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013. Euro Surveill. 2018; 23:17–00454.

2. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995; 123:518–527.

3. Doll MK, Winters N, Boikos C, Kraicer-Melamed H, Gore G, Quach C. Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses. J Antimicrob Chemother. 2017; 72:2990–3007.

4. Park O, Choi BY. Introduction and evaluation of communicable disease surveillance in the republic of Korea. J Prev Med Public Health. 2007; 40:259–264.

5. Sanicas M, Forleo E, Pozzi G, Diop D. A review of the surveillance systems of influenza in selected countries in the tropical region. Pan Afr Med J. 2014; 19:121.

6. Thommes EW, Kruse M, Kohli M, Sharma R, Noorduyn SG. Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines. Hum Vaccin Immunother. 2017; 13:867–876.

7. Sambala EZ, Ndwandwe DE, Imaan LM, Wiysonge CS. Evaluation of influenza surveillance systems in sub-Saharan Africa: a systematic review protocol. BMJ Open. 2019; 9:e023335.

8. Yang P, Duan W, Lv M, Shi W, Peng X, Wang X, Lu Y, Liang H, Seale H, Pang X, Wang Q. Review of an influenza surveillance system, Beijing, People's Republic of China. Emerg Infect Dis. 2009; 15:1603–1608.

9. Kim WJ, Noh JY, Park MS, Song JY, Shin O, Ahn DH, Wie SH, Lee JS, Jang J, Cheong HJ, Chun BC, Choi YK, Choi WS. Influenza. Seoul: Transgovernmental Enterprise for Pandemic Influenza in Korea;2016.

10. Ziegler T, Mamahit A, Cox NJ. 65 years of influenza surveillance by a World Health Organization-coordinated global network. Influenza Other Respir Viruses. 2018; 12:558–565.

11. World Heaith Organization. Global influenza surveillance and response system (GISRS). Accessed 22 April 2019. Available at: https://www.who.int/influenza/gisrs_laboratory/en/.

12. Chaiyakunapruk N, Kotirum S, Newall AT, Lambach P, Hutubessy RCW. Rationale and opportunities in estimating the economic burden of seasonal influenza across countries using a standardized WHO tool and manual. Influenza Other Respir Viruses. 2018; 12:13–21.

13. Oliva J, Delgado-Sanz C, Larrauri A. Spanish Influenza Surveillance System. Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016. Influenza Other Respir Viruses. 2018; 12:161–170.

14. Schanzer DL, Saboui M, Lee L, Nwosu A, Bancej C. Burden of influenza, respiratory syncytial virus, and other respiratory viruses and the completeness of respiratory viral identification among respiratory inpatients, Canada, 2003-2014. Influenza Other Respir Viruses. 2018; 12:113–121.

15. Simmerman JM, Uyeki TM. The burden of influenza in East and South-East Asia: a review of the English language literature. Influenza Other Respir Viruses. 2008; 2:81–92.

16. Bresee J, Fitzner J, Campbell H, Cohen C, Cozza V, Jara J, Krishnan A, Lee V, Working WH. WHO Working Group on the Burden of Influenza Disease. Group on the Burden of Influenza Disease. Progress and remaining gaps in estimating the global disease burden of influenza. Emerg Infect Dis. 2018; 24:1173–1177.

17. Centers for Disease Control and Prevention. Overview of influenza surveillance in the United States. Accessed 22 April 2019. Available at: https://www.cdc.gov/flu/weekly/overview.htm.

18. Centers for Disease Control and Prevention. CDC seasonal flu vaccine effectiveness studies. Accessed 22 April 2019. Available at: https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm.

19. Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breese Hall C, Monto AS, Griffin MR, Belongia E, Shay DK. US Flu-VE Network. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis. 2012; 55:951–959.

20. Ferdinands JM, Gaglani M, Martin ET, Middleton D, Monto AS, Murthy K, Silveira FP, Talbot HK, Zimmerman R, Alyanak E, Strickland C, Spencer S, Fry AM. HAIVEN Study Investigators. Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). J Infect Dis. 2018; Epub ahead of print.

21. Rolfes MA, Foppa IM, Garg S, Flannery B, Brammer L, Singleton JA, Burns E, Jernigan D, Olsen SJ, Bresee J, Reed C. Annual estimates of the burden of seasonal influenza in the United States: a tool for strengthening influenza surveillance and preparedness. Influenza Other Respir Viruses. 2018; 12:132–137.

22. European Centre for Disease Prevention and Control. European influenza surveillance network (EISN). Accessed 2 April 2019. Available at: https://ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/eisn.

23. Zaraket H, Saito R. Japanese surveillance systems and treatment for influenza. Curr Treat Options Infect Dis. 2016; 8:311–328.

24. Korea Centers for Disease Control and Prevention (KCDC). 2018-2019 season influenza management guideline. Osong: KCDC;2018.

25. Seo YB, Song JY, Cheong HJ, Cho YD, Wie SH, Jeong HW, Kim WJ. Hospital-based influenza morbidity and mortality surveillance system for influenza-like illnesses: a comparison with national influenza surveillance systems. Influenza Other Respir Viruses. 2014; 8:17–20.

26. Hong KW, Cheong HJ, Choi WS, Lee J, Wie SH, Baek JH, Kim HY, Jeong HW, Kim WJ. Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance. J Infect Chemother. 2014; 20:9–14.

27. Kang SH, Cheong HJ, Song JY, Noh JY, Jeon JH, Choi MJ, Lee J, Seo YB, Lee JS, Wie SH, Jeong HW, Kim YK, Park KH, Kim SW, Jeong EJ, Lee SH, Choi WS, Kim WJ. Analysis of risk factors for severe acute respiratory infection and pneumonia and among adult patients with acute respiratory illness during 2011-2014 influenza seasons in Korea. Infect Chemother. 2016; 48:294–301.

28. Choi WS, Cowling BJ, Noh JY, Song JY, Wie SH, Lee JS, Seo YB, Lee J, Jeong HW, Kim YK, Kim SW, Park KH, Lee SH, Cheong HJ, Kim WJ. Disease burden of 2013-2014 seasonal influenza in adults in Korea. PLoS One. 2017; 12:e0172012.

29. Lee HS, Noh JY, Song JY, Cheong HJ, Choi WS, Jeong HW, Wie SH, Kim WJ. Molecular genetic characteristics of influenza A virus clinically isolated during 2011-2016 influenza seasons in Korea. Influenza Other Respir Viruses. 2018; 12:497–507.

30. Song JY, Noh JY, Lee J, Woo HJ, Lee JS, Wie SH, Kim YK, Jeong HW, Kim SW, Lee SH, Park KH, Kang SH, Kee SY, Kim TH, Choo EJ, Lee HS, Choi WS, Cheong HJ, Kim WJ. Hospital-based influenza morbidity and mortality (HIMM) surveillance for A/H7N9 influenza virus infection in returning travelers. J Korean Med Sci. 2018; 33:e49.

31. Korea Centers for Disease Control and Prevention (KCDC). National immunization program management guideline for 2017-2018 seonal influenza. Osong: KCDC;2017.